Option Care Health, Inc.

OPCH · NasdaqGS · Stock · Healthcare
$31.12
+0.06% today
Delayed price,

What Option Care Health does

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Key facts

Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$4.66B
P/E (ttm)
23.6
Forward P/E
14.9
Dividend yield
0.00%
Beta
0.58
Profit margin
3.7%
Employees
8,000
Headquarters
Bannockburn, IL, United States
Exchange
NasdaqGS

Performance

1 Month
+28.1%
3 Months
+43.1%
6 Months
+8.0%
1 Year
+12.1%
5 Years
+23.0%
$18.0152-week range$36.80
Biggest setback — last 12 months
-46.2%
19 Jan 2026 → 11 May 2026
Fell from $36.27 to $19.52 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+59.4%
11 May 2026 → 14 Oct 2026
Ran from $19.52 to $31.12 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$26.44 (-15.0%)$31.12$36.63 (+17.7%)
3 Months$23.46 (-24.6%)$31.12$41.27 (+32.6%)
6 Months$20.87 (-32.9%)$31.12$46.39 (+49.1%)
12 Months$17.69 (-43.1%)$31.12$54.74 (+75.9%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 56.5%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.